1. Home
  2. JAGX vs BBLG Comparison

JAGX vs BBLG Comparison

Compare JAGX & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$0.49

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

BBLG

Bone Biologics Corp

N/A

Current Price

$1.22

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
BBLG
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.6M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JAGX
BBLG
Price
$0.49
$1.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
400.4K
23.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,689,000.00
N/A
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.75
N/A
52 Week Low
$0.20
$0.57
52 Week High
$15.48
$5.98

Technical Indicators

Market Signals
Indicator
JAGX
BBLG
Relative Strength Index (RSI) 36.69 41.11
Support Level N/A $1.11
Resistance Level $0.69 $1.88
Average True Range (ATR) 0.10 0.08
MACD -0.01 0.02
Stochastic Oscillator 1.58 42.86

Price Performance

Historical Comparison
JAGX
BBLG

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: